Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025

DBVT (NYSE Euronext Paris, ISIN: FR0010417345) announced the total number of shares and voting rights as of December 31, 2025 in accordance with Article 223-16 of the AMF General Regulations.

Rhea-AI Summary

DBVT (NYSE Euronext Paris, ISIN: FR0010417345) announced the total number of shares and voting rights as of December 31, 2025 in accordance with Article 223-16 of the AMF General Regulations.

The company reported a total number of shares of 232,207,589, a total gross of voting rights of 232,207,589, and a total net of voting rights of 232,133,009 (net excludes shares without voting rights). A PDF attachment is available for the detailed statement.

Argus Jan 6 session

-2.12% close to close Open Argus

Details

News Market Reaction – DBVT

In the Jan 6 session, DBVT declined 2.12%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement reports the total number of shares and voting rights as of Dec 31, 2025, following...

Analysis

This announcement reports the total number of shares and voting rights as of Dec 31, 2025, following a similar disclosure for Nov 30, 2025. It clarifies the gross and net voting rights, accounting for shares without voting rights. In the broader context of recent clinical milestones and governance updates, this filing is mainly procedural. Investors may monitor future clinical, regulatory, and financing developments alongside ongoing changes in the share and voting-rights structure.

Key Figures

Total shares: 232,207,589 Total gross voting rights: 232,207,589 Total net voting rights: 232,133,009

Total shares

232,207,589

Outstanding as of 12/31/2025

Total gross voting rights

232,207,589

As of 12/31/2025 under AMF Article 223-16

Total net voting rights

232,133,009

Excludes shares without voting rights, as of 12/31/2025

Historical Context

5 past events · Latest: Dec 16

5 events

1. Dec 16

   Phase 3 results

   24h Move

   -1.7%

   Positive Phase 3 VITESSE topline data for VIASKIN Peanut in children 4–7.

2. Dec 02

   Capital structure update

   24h Move

   -0.6%

   Monthly disclosure of total shares and voting rights as of Nov 30, 2025.

3. Nov 11

   Trial progress

   24h Move

   -1.8%

   Completion of last patient visit in VITESSE Phase 3 VIASKIN Peanut trial.

4. Nov 04

   Conference participation

   24h Move

   +0.8%

   Announcement of participation in Guggenheim Healthcare Innovation Conference.

5. Nov 03

   Executive appointment

   24h Move

   -2.7%

   Appointment of a new Chief Commercial Officer for VIASKIN Peanut strategy.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

isin

1 terms

isin financial

"Market : NYSE Euronext Paris ISIN Code: FR 0010417345"

A 12-character International Securities Identification Number (ISIN) is a unique code that acts like a passport for a specific stock, bond or other tradable security so it can be identified worldwide. Investors and systems use it to ensure they are buying, selling and tracking the exact same instrument across exchanges and data feeds, which prevents costly mix-ups and makes portfolio reporting, settlement and regulatory checks simpler and more reliable.

View in glossary

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Information Regarding the Total Number of Voting Rights and 
Total Number of Shares of the Company as of December 31, 2025

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345

Date	Total number of shares	Total number of voting rights
12/31/2025	232,207,589	Total gross of voting rights: 232,207,589
		Total net* of voting rights: 232,133,009

* Net total = total number of voting rights attached to shares – shares without voting rights

Attachment

• PDF Version

FAQ

What are the total number of shares and voting rights for DBVT as of December 31, 2025?

DBVT reported 232,207,589 total shares, 232,207,589 gross voting rights, and 232,133,009 net voting rights as of Dec 31, 2025.

What is the difference between gross and net voting rights for DBVT (DBVT) on Dec 31, 2025?

Gross voting rights equal all voting rights attached to shares; net voting rights (232,133,009) exclude shares without voting rights.

Where can investors find DBVT's full statement of voting rights for December 31, 2025?

The company published the statement with an attachment PDF alongside the disclosure filed under Article 223-16 of the AMF General Regulations.

Which ISIN and market are listed for DBVT in the December 31, 2025 voting rights disclosure?

The disclosure lists ISIN FR0010417345 and market NYSE Euronext Paris.

Does DBVT's reported share count on Dec 31, 2025 affect shareholder voting power immediately?

The figures define the universe of voting rights at Dec 31, 2025; any change in voting power depends on subsequent transactions or corporate actions after that date.